Pages that link to "Q37748188"

The following pages link to The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application (Q37748188):

Displaying 24 items.

• The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia (Q26798193) (← links)
• The Robyn Barst Memorial Lecture: Differences between the fetal, newborn, and adult pulmonary circulations: relevance for age-specific therapies (2013 Grover Conference series) (Q26862046) (← links)
• If we know so much about preeclampsia, why haven't we cured the disease? (Q27009441) (← links)
• Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia (Q27025986) (← links)
• A cohort evaluation on arterial stiffness and hypertensive disorders in pregnancy (Q34523176) (← links)
• First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia (Q35532857) (← links)
• Preeclampsia - Aetiology, Current Diagnostics and Clinical Management, New Therapy Options and Future Perspectives (Q36295102) (← links)
• Placental endoplasmic reticulum stress negatively regulates transcription of placental growth factor via ATF4 and ATF6β: implications for the pathophysiology of human pregnancy complications (Q36667589) (← links)
• Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia (Q37107851) (← links)
• Biomarkers for the management of pre-eclampsia in pregnant women. (Q37156676) (← links)
• Circulating Vascular Growth Factor (VEGF) Angiopoietin-1 (Angi-1) and Soluble Tie-2 Receptor in Pregnancy Complicated with Pre-eclampsia: A Prospective Study (Q37233880) (← links)
• An Elevated Maternal Plasma Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio at Midtrimester Is a Useful Predictor for Preeclampsia (Q37400597) (← links)
• Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia (Q38642726) (← links)
• Budget impact analysis of sFlt-1/PlGF ratio as prediction test in Italian women with suspected preeclampsia (Q38979806) (← links)
• Serum levels of platelet endothelial cell adhesion molecule-1 (PECAM-1) and soluble vascular endothelial growth factor receptor (sVEGFR)-1 and -2 in HIV associated preeclampsia (Q40174475) (← links)
• Statistical regression model of standard and new laboratory markers and its usefulness in prediction of preeclampsia (Q44652577) (← links)
• Increased Placental Growth Factor in Cerebrospinal Fluid of Patients with Epilepsy (Q44880009) (← links)
• Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective (Q46329159) (← links)
• Are there financial savings associated with supplementing current diagnostic practice for preeclampsia with a novel test? Learnings from a modeling analysis from a German payer perspective (Q46479004) (← links)
• Separation and characterization of maternal cardiac and vascular sounds in the third trimester of pregnancy. (Q47417854) (← links)
• Early pregnancy angiogenic proteins levels and pregnancy related hypertensive disorders (Q50660057) (← links)
• Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population. (Q55066995) (← links)
• Assessment of angiogenesis modulators in pregnant women with pre-eclampsia: a case–control study (Q56449434) (← links)
• Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women (Q92511804) (← links)